Fortress Biotech, Inc. (FBIOP) trades at a trailing P/E of 9.5, forward P/E of 26.5. Trailing earnings yield is 10.57%, forward earnings yield 3.78%. Graham Number is $3.50.
Criteria proven by this page:
Overall SharesGrow Score: 45/100 with 2/7 criteria passed.
| Year | P/E (TTM) | PEG Ratio | P/B Ratio | P/S Ratio | Dividend Yield |
|---|---|---|---|---|---|
| 2016 | -2.0 | -0.17 | 2.80 | 6.55 | - |
| 2017 | -2.5 | -0.15 | 3.16 | 0.89 | 0.18% |
| 2018 | -0.4 | -0.02 | 20.18 | 1.39 | 6.27% |
| 2019 | -3.5 | 0.06 | 5.36 | 3.84 | 1.82% |
| 2020 | -4.9 | 0.45 | 2.27 | 5.01 | 2.96% |
| 2021 | -3.2 | -0.15 | 1.88 | 2.97 | 4.30% |
| 2022 | -0.7 | -0.03 | 1.41 | 0.77 | 14.97% |
| 2023 | -0.4 | 0.01 | 1.08 | 0.29 | 35.91% |
| 2024 | -0.9 | 0.01 | 1.86 | 0.73 | 11.16% |
| 2025 | 15.0 | -0.15 | 2.05 | 1.61 | 0.65% |
| Year | EPS (Diluted) | Revenue | Net Income | Net Margin |
|---|---|---|---|---|
| 2016 | $-20.68 | $16.48M | $-55.1M | -334.3% |
| 2017 | $-24.08 | $187.58M | $-66.88M | -35.7% |
| 2018 | $-29.04 | $26.88M | $-84.15M | -313% |
| 2019 | $-10.95 | $36.63M | $-39.96M | -109.1% |
| 2020 | $-9.75 | $45.6M | $-46.53M | -102% |
| 2021 | $-11.85 | $68.79M | $-64.7M | -94.1% |
| 2022 | $-14.55 | $75.74M | $-86.58M | -114.3% |
| 2023 | $-8.47 | $84.51M | $-60.64M | -71.7% |
| 2024 | $-2.69 | $57.68M | $-46M | -79.8% |
| 2025 | $-0.07 | $61.24M | $-32.92M | -53.7% |
| Year | EPS (Avg) | EPS Range | Revenue (Avg) | Revenue Range | Analysts |
|---|---|---|---|---|---|
| 2026 | $0.62 | $0.62 – $0.62 | $110.8M | $109.51M – $112.09M | 1 |
| 2027 | $1.51 | $1.50 – $1.52 | $145.3M | $144.57M – $146.03M | 1 |
